Nuvation Bio Files 8-K on Operations and Financials
Ticker: NUVB · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1811063
Sentiment: neutral
Topics: corporate-filing, financials, operations
Related Tickers: NUVB
TL;DR
Nuvation Bio filed an 8-K on Aug 5th, updating on financials and operations. Check their San Francisco HQ.
AI Summary
Nuvation Bio Inc. filed an 8-K on August 5, 2024, reporting on its results of operations and financial condition. The filing indicates the company's incorporation in Delaware and provides its business and mailing addresses in San Francisco, CA. It also lists its IRS number and fiscal year end.
Why It Matters
This 8-K filing provides essential corporate and financial information for Nuvation Bio Inc., which is crucial for investors and stakeholders to understand the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Numbers
- 001-39351 — SEC File Number (Identifies the company's filing with the SEC)
- 85-0862255 — IRS Number (Company's Employer Identification Number)
Key Players & Entities
- Nuvation Bio Inc. (company) — Registrant
- August 5, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Francisco, CA (location) — Business and mailing address
- Panacea Acquisition Corp (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Nuvation Bio Inc.'s results of operations and financial condition.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on August 5, 2024.
In which state is Nuvation Bio Inc. incorporated?
Nuvation Bio Inc. is incorporated in Delaware.
What are Nuvation Bio Inc.'s business and mailing addresses?
Nuvation Bio Inc.'s business and mailing addresses are located at 357 Tehama Street, Floor 3, San Francisco, CA 94103.
What was Nuvation Bio Inc.'s former company name?
Nuvation Bio Inc.'s former company name was Panacea Acquisition Corp.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-08-05 08:37:33
Key Financial Figures
- $0.0001 — change on which Class A Common Stock, $0.0001 par value per share NUVB The New Yo
- $11.50 — of Common Stock at an exercise price of $11.50 per share NUVB.WS The New York Stoc
Filing Documents
- d867853d8k.htm (8-K) — 27KB
- d867853dex991.htm (EX-99.1) — 92KB
- g867853g0802221321613.jpg (GRAPHIC) — 4KB
- 0001193125-24-193412.txt ( ) — 295KB
- nuvb-20240805.xsd (EX-101.SCH) — 4KB
- nuvb-20240805_def.xml (EX-101.DEF) — 14KB
- nuvb-20240805_lab.xml (EX-101.LAB) — 23KB
- nuvb-20240805_pre.xml (EX-101.PRE) — 15KB
- d867853d8k_htm.xml (XML) — 6KB
FINANCIAL STATEMENTS AND EXHIBITS
FINANCIAL STATEMENTS AND EXHIBITS (d)Exhibits. Exhibit Number Description 99.1 Press Release of Nuvation Bio Inc. dated August 5, 2024. 104 Cover Page Interactive Data File (embedded within XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 5, 2024 NUVATION BIO INC. By: /s/ Moses Makunje Name: Moses Makunje Title: VP, Finance, Principal Financial and Accounting Officer 3